30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dave Mott

Track

Insider profile

Currently holds positions in Ardelyx Inc, Epizyme Inc, Mersana Therapeutics Inc and Adaptimmune Therapeutics PLC

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
54 94% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Ardelyx Inc March 1, 2014 -
Independent Chairman of the Board Epizyme Inc April 1, 2016 -
Independent Chairman of the Board Mersana Therapeutics Inc Jan. 1, 2017 -
Non-Executive Independent Chairman of the Board Adaptimmune Therapeutics PLC Jan. 1, 2017 -
Independent Chairman of the Board TESARO Inc July 1, 2011 - Jan. 22, 2019
Chairman of the Board Mersana Therapeutics Inc Nov. 1, 2013 - Jan. 1, 2017
Non-Executive Vice Chairman of the Board Adaptimmune Therapeutics PLC May 24, 2016 - Jan. 1, 2017
Non-Executive Independent Director Adaptimmune Therapeutics PLC Sept. 1, 2014 - May 24, 2016
Independent Director Epizyme Inc Dec. 1, 2009 - April 1, 2016
Director Ardelyx Inc March 1, 2009 - March 1, 2014
Chairman of the Board Mersana Therapeutics Inc July 1, 2012 - Nov. 1, 2013
Dave Mott's trades of Ardelyx Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-23 2026-02-20
US Ardelyx Inc (ARDX)
B Purchase
68,618 +14.5%
457.35
US$927,749 		68,618 +14.5% 457.35 US$927,749
2025-06-18 2025-06-16
US Ardelyx Inc (ARDX)
B Purchase
89,065 +26.0%
473.83
US$3,736,041 		89,065 +26.0% 473.83 US$3,736,041
2025-06-11 2025-06-09
US Ardelyx Inc (ARDX)
B Purchase
51,124 -40.6%
408.21
US$4,989,070 		51,124 -40.6% 408.21 US$4,989,070
2025-05-19 2025-05-15
US Ardelyx Inc (ARDX)
B Purchase
100,000 +4.2%
3.29
US$329,120 		100,000 +4.2% 3.29 US$329,120
2025-05-05 2025-05-02
US Ardelyx Inc (ARDX)
B Purchase
381,377 +18.9%
4.22
US$1,610,936 		381,377 +18.9% 4.22 US$1,610,936
2025-02-26 2025-02-24
US Ardelyx Inc (ARDX)
B Purchase
77,729 +4.0%
5.00
US$388,738 		77,729 +4.0% 5.00 US$388,738
2025-01-22 2025-01-21
US Ardelyx Inc (ARDX)
B Purchase
199,000 +11.4%
4.99
US$992,672 		199,000 +11.4% 4.99 US$992,672
2024-12-23 2024-12-19
US Ardelyx Inc (ARDX)
B Purchase
213,300 +15.0%
4.67
US$996,580 		213,300 +15.0% 4.67 US$996,580
2024-11-14 2024-11-13
US Ardelyx Inc (ARDX)
B Purchase
215,868 +17.8%
4.62
US$996,598 		215,868 +17.8% 4.62 US$996,598
2022-11-17 2022-11-17
US Ardelyx Inc (ARDX)
B Purchase
567,000 +94.5%
1.76
US$1,000,642 		567,000 +94.5% 1.76 US$1,000,642
2022-02-23 2022-02-23
B Purchase
35,257 +18.2%
1.46
US$51,475 		35,257 +18.2% 1.46 US$51,475
2022-02-23 2022-02-22
B Purchase
65,817 +51.4%
1.56
US$102,675 		65,817 +51.4% 1.56 US$102,675
2022-02-23 2022-02-18
B Purchase
50,398 +64.8%
1.30
US$65,517 		50,398 +64.8% 1.30 US$65,517
2022-02-17 2022-02-17
B Purchase
14,595 +23.1%
1.17
US$17,076 		14,595 +23.1% 1.17 US$17,076
2022-02-17 2022-02-16
B Purchase
11,779 +22.9%
1.20
US$14,135 		11,779 +22.9% 1.20 US$14,135
2022-02-17 2022-02-15
B Purchase
19,552 +61.4%
1.20
US$23,462 		19,552 +61.4% 1.20 US$23,462
2022-02-14 2022-02-14
B Purchase
8,500 +36.4%
1.18
US$10,030 		8,500 +36.4% 1.18 US$10,030
2022-02-14 2022-02-11
B Purchase
14,573 +166.5%
1.23
US$17,925 		14,573 +166.5% 1.23 US$17,925
2022-02-14 2022-02-10
B Purchase
8,753 +inf%
1.29
US$11,291 		8,753 +inf% 1.29 US$11,291
2021-03-29 2021-03-26
US Epizyme Inc (EPZM)
B Purchase
217 +0.1%
7.80
US$1,693 		217 +0.1% 7.80 US$1,693
2021-03-29 2021-03-26
US Epizyme Inc (EPZM)
B Purchase
34,269 +29.4%
7.97
US$273,124 		34,269 +29.4% 7.97 US$273,124
2021-03-29 2021-03-25
US Epizyme Inc (EPZM)
B Purchase
28,231 +32.0%
7.98
US$225,283 		28,231 +32.0% 7.98 US$225,283
2020-12-10 2020-12-10
US Ardelyx Inc (ARDX)
B Purchase
170,000 +68.7%
5.89
US$1,000,841 		170,000 +68.7% 5.89 US$1,000,841
2020-06-26 2020-06-26
US Epizyme Inc (EPZM)
B Purchase
62,019 +301.3%
16.03
US$994,165 		62,019 +301.3% 16.03 US$994,165
2020-06-26 2020-06-25
US Ardelyx Inc (ARDX)
B Purchase
68,373 +38.2%
6.96
US$476,040 		68,373 +38.2% 6.96 US$476,040
2020-06-26 2020-06-24
US Ardelyx Inc (ARDX)
B Purchase
72,598 +68.3%
6.75
US$489,862 		72,598 +68.3% 6.75 US$489,862
2020-06-24 2020-06-22
US Ardelyx Inc (ARDX)
B Purchase
4,673 +4.6%
6.75
US$31,525 		4,673 +4.6% 6.75 US$31,525
2020-04-09 2020-04-07
B Purchase
538,599 +inf%
5.59
US$3,010,768 		538,599 +inf% 5.59 US$3,010,768
2020-01-28 2020-01-24
B Purchase
7,500,000 +62.5%
0.67
US$5,000,250 		7,500,000 +62.5% 0.67 US$5,000,250
2019-07-24 2019-07-22
B Purchase
450,000 +12.0%
15.00
US$6,750,000 		450,000 +12.0% 15.00 US$6,750,000
2019-06-28 2019-06-27
US Epizyme Inc (EPZM)
S Sale
52,473 -100.0%
12.43
US$652,134 		52,473 -100.0% 12.43 US$652,134
2019-06-26 2019-06-26
US Epizyme Inc (EPZM)
S Sale
52,472 -50.0%
12.85
US$674,176 		52,472 -50.0% 12.85 US$674,176
2019-06-26 2019-06-25
US Epizyme Inc (EPZM)
S Sale
52,472 -33.3%
13.31
US$698,649 		52,472 -33.3% 13.31 US$698,649
2019-06-25 2019-06-24
B Purchase
2,857,142 +65.4%
3.50
US$9,999,997 		2,857,142 +65.4% 3.50 US$9,999,997
2019-05-13 2019-05-09
B Purchase
1,500,000 +51.0%
10.00
US$15,000,000 		1,500,000 +51.0% 10.00 US$15,000,000
2019-05-13 2019-05-09
B Purchase
1,000,000 +51.6%
10.00
US$10,000,000 		1,000,000 +51.6% 10.00 US$10,000,000
2019-05-09 2019-05-07
B Purchase
1,136,704 +124.1%
1.08
US$1,227,640 		1,136,704 +124.1% 1.08 US$1,227,640
2019-04-08 2019-04-08
B Purchase
4,347,827 +20.8%
1.14
US$4,956,523 		4,347,827 +20.8% 1.14 US$4,956,523
2019-03-06 2019-03-05
B Purchase
3,750,000 +46.1%
4.00
US$15,000,000 		3,750,000 +46.1% 4.00 US$15,000,000
2019-02-19 2019-02-14
B Purchase
9,948,269 +39.8%
0.47
US$4,688,619 		9,948,269 +39.8% 0.47 US$4,688,619
2018-12-21 2018-12-21
B Purchase
300,000 +1.5%
1.49
US$448,380 		300,000 +1.5% 1.49 US$448,380
2018-12-21 2018-12-20
B Purchase
200,000 +1.0%
1.63
US$326,060 		200,000 +1.0% 1.63 US$326,060
2018-12-12 2018-12-11
B Purchase
61,200 +0.3%
1.98
US$121,084 		61,200 +0.3% 1.98 US$121,084
2018-12-10 2018-12-10
B Purchase
26,000 +0.1%
1.98
US$51,576 		26,000 +0.1% 1.98 US$51,576
2018-12-10 2018-12-07
B Purchase
117,100 +0.6%
1.98
US$232,362 		117,100 +0.6% 1.98 US$232,362